Yuji Yamazaki

15PUBLICATIONS
25CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer cell biologyFood engineeringGene expression (incl. microarray and other genome-wide approaches)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 25, 2026
Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe.

|Apr 15, 2026
ChREBP drives β-cell proliferation under metabolic stress but not in pregnancy-induced β-cell expansion.

Sodai Kubota, Seiya Banno, Katsumi Iizuka

|Mar 28, 2026
c-Jun N-terminal kinase 3 as a permissive regulator of β-cell incretin responsiveness.

Yuji Yamazaki

|Feb 03, 2026
Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice.

Saki Kubota-Okamoto, Sodai Kubota, Hiromi Tsuchida

|Jan 20, 2026
Retrospective comparison of the clinical effects of oral semaglutide and SGLT2 inhibitors treatment in patients with type 2 diabetes.

Yasuhiro Omori, Ryota Usui, Yuji Yamazaki

|Oct 27, 2025
Fat Quality, Not Just Quantity: Incretin-Based Therapy and Fat Composition in Type 2 Diabetes.

Akito Nakatani, Mari Matsushiro, Yuko Yamaguchi

Pageof 3

Frequent Collaborators

6 joint publications

Yutaka Seino

4 joint publications

Yoshiyuki Hamamoto

3 joint publications

Ryota Usui

3 joint publications

Takaaki Murakami